Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain. ketamine, astrocytic inhibitor and pain
<p>Abstract</p> <p>Background</p> <p>Neuropathic pain is an intractable clinical problem. Intrathecal ketamine, a noncompetitive N--methyl-D-aspartate receptor (NMDAR) antagonist, is reported to be useful for treating neuropathic pain in clinic by inhibiting the activit...
Saved in:
Main Authors: | Mei Xiao-Peng (Author), Wang Wei (Author), Wang Wen (Author), Zhu Chao (Author), Chen Lei (Author), Zhang Ting (Author), Xu Li-Xian (Author), Wu Sheng-Xi (Author), Li Yun-Qing (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2010-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Goshajinkigan attenuates paclitaxel‐induced neuropathic pain via cortical astrocytes
by: Kenta Takanashi, et al.
Published: (2021) -
Analgesic effect of intranasal ketamine in the treatment of chronic cancer pain
by: Secundino González Pardo, et al.
Published: (2022) -
Contribution of microglia and astrocytes to the central sensitization, inflammatory and neuropathic pain in the juvenile rat
by: Ikeda Hiroshi, et al.
Published: (2012) -
Impaired amygdala astrocytic signaling worsens neuropathic pain-associated neuronal functions and behaviors
by: Mariacristina Mazzitelli, et al.
Published: (2024) -
Use of Ketamine in Patients with Multifactorial Neuropathic Pain: A Systematic Review and Meta-Analysis
by: Alejandro Bruna-Mejias, et al.
Published: (2024)